---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042569"
form_type: "8-K"
ticker: "KAPA"
cik: "0001962011"
company_name: "Kairos Pharma, LTD."
filed_at: "2026-09-14T20:00:42+00:00"
generated_at: "2026-09-14T20:02:11.243459+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Kairos Pharma issues investor presentation; CEO to present at H.C. Wainwright conference

## Summary
- Chief Executive Officer John Yu to present at H.C. Wainwright 28th Annual Global Investment Conference in New York, Sept 14-16, 2026.
- Presentation provides update on clinical program and activities; published on company website.
- No financial, clinical, or guidance figures disclosed in the 8-K filing text.

## SEC filing metadata
- accession: 0001493152-26-042569
- form_type: 8-K
- ticker: KAPA
- cik: 0001962011
- company_name: Kairos Pharma, LTD.
- filed_at: 2026-09-14T20:00:42+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1962011/000149315226042569/0001493152-26-042569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1962011/000149315226042569/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042569
- JSON: https://secwatch.observer/filing/0001493152-26-042569.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042569.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.